Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase II Study in Relapsing Glioblastoma of Intraarterial Concurrent Chemoradiation Therapy Using IA Carboplatin

NCT03672721 is registered in ClinicalTrials.gov with Université de Sherbrooke as lead sponsor.

NCT NCT03672721
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03672721 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase II Study in Relapsing Glioblastoma of Intraarterial Concurrent Chemoradiation Therapy Using IA Carboplatin
Lead sponsor
Université de Sherbrooke
Phase
Phase 1/2
Overall status
Recruiting
Start date
July 10, 2018
Completion date
June 10, 2026
Enrollment
35 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

glioblastoma multiforme, relapse